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Evaluation of point‐of‐care thoracic ultrasound and NT‐proBNP for the
diagnosis of congestive heart failure in cats with respiratory distress
Abstract
Background The diagnosis of congestive heart failure (CHF) in cats is challenging. Point‐of‐care (POC)
thoracic ultrasound and NT‐proBNP testing are emerging tools that may aid in diagnosis.
Hypothesis/Objectives To assess the diagnostic accuracy of POC lung ultrasound (LUS), focused cardiac
ultrasound (FCU), and NT‐proBNP in predicting a final diagnosis of CHF.
Animals Fifty‐one cats in respiratory distress.
Methods Blood NT‐proBNP, LUS, and FCU evaluating left atrial (LA) size and presence of pericardial
effusion (PCEFF) were performed in all cats. Lung ultrasound findings including pleural effusion (PLEFF),
number of B‐lines, and sub‐pleural abnormalities were noted. Medical records were evaluated for final
diagnosis.
Results Thirty‐three of 51 (65%) cats were diagnosed with CHF. Lung ultrasound and blood NT‐proBNP
were significant predictors of CHF in a multivariate model. The LUS criterion that maximized accuracy for
CHF diagnosis was presence of >1 site strongly positive for B‐lines (>3 B‐lines per site), resulting in
sensitivity of 78.8%, specificity of 83.3%, and area under the curve (AUC) of 0.833. Subjective LA
enlargement was 97.0% sensitive and 100% specific for CHF (AUC 0.985). Presence of PCEFF also was
100% specific, but only 60.6% sensitive, for CHF (AUC 0.803). A positive blood NT‐proBNP test was 93.9%
sensitive and 72.2% specific for the diagnosis of CHF (AUC 0.831).
Conclusions and Clinical Importance Point‐of‐care diagnostic techniques of LUS, FCU, and NT‐proBNP
are useful to diagnose CHF in cats with respiratory distress.
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Background: The diagnosis of congestive heart failure (CHF) in cats is challenging. Point-of-care
(POC) thoracic ultrasound and NT-proBNP testing are emerging tools that may aid in diagnosis.
Hypothesis/Objectives: To assess the diagnostic accuracy of POC lung ultrasound (LUS),
focused cardiac ultrasound (FCU), and NT-proBNP in predicting a final diagnosis of CHF.
Animals: Fifty-one cats in respiratory distress.
Methods: Blood NT-proBNP, LUS, and FCU evaluating left atrial (LA) size and presence of peri-
cardial effusion (PCEFF) were performed in all cats. Lung ultrasound findings including pleural
effusion (PLEFF), number of B-lines, and sub-pleural abnormalities were noted. Medical records
were evaluated for final diagnosis.
Results: Thirty-three of 51 (65%) cats were diagnosed with CHF. Lung ultrasound and blood
NT-proBNP were significant predictors of CHF in a multivariate model. The LUS criterion that
maximized accuracy for CHF diagnosis was presence of >1 site strongly positive for B-lines (>3
B-lines per site), resulting in sensitivity of 78.8%, specificity of 83.3%, and area under the curve
(AUC) of 0.833. Subjective LA enlargement was 97.0% sensitive and 100% specific for CHF
(AUC 0.985). Presence of PCEFF also was 100% specific, but only 60.6% sensitive, for CHF
(AUC 0.803). A positive blood NT-proBNP test was 93.9% sensitive and 72.2% specific for the
diagnosis of CHF (AUC 0.831).
Conclusions and Clinical Importance: Point-of-care diagnostic techniques of LUS, FCU, and NT-
proBNP are useful to diagnose CHF in cats with respiratory distress.
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B-lines, biomarker, cardiac, feline, lung, point-of-care, respiratory
1 | INTRODUCTION
Congestive heart failure (CHF) is a common cause of respiratory dis-
tress in cats. The diagnosis of CHF in cats is especially challenging, not
only because the fragility of cats in respiratory distress limits the diag-
nostic evaluation, but also because physical examination and radio-
graphic findings in cats often are nonspecific. Up to 40% of cats in
CHF may not have a heart murmur upon initial examination for respi-
ratory distress.1–3 Moreover, radiographic evidence of pulmonary
Abbreviations: AUC, area under the receiver operating characteristic curve;
CHF, congestive heart failure; FCU, focused cardiac ultrasound; LA, left atrium;
LA : Ao, left atrium to aorta ratio; LUS, lung ultrasound; NC, noncardiac; PCEFF,
pericardial effusion; PLEFF, pleural effusion; POC, point of care; SD, standard
deviation; TXR, thoracic radiographs; Vet BLUE, veterinary bedside lung ultra-
sound examination.
Received: 17 December 2017 Revised: 3 March 2018 Accepted: 22 May 2018
DOI: 10.1111/jvim.15246
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited and is not used for commercial purposes. © 2018 The Authors. Journal of Veterinary Internal Medicine published
by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.
1530 wileyonlinelibrary.com/journal/jvim J Vet Intern Med. 2018;32:1530–1540.
edema, left atrial (LA) enlargement, and pulmonary venous distention
are notoriously variable in cats with CHF, further complicating the
diagnosis.4,5
Other diagnostic modalities, such as point-of-care (POC) bio-
marker testing and ultrasound imaging, are emerging to facilitate a
more timely diagnosis and directed treatment of CHF in cats. The POC
N-terminal pro-B-type natriuretic peptide (NT-proBNP) test (SNAP
Feline proBNP; SNAP Feline proBNP test, IDEXX Laboratories, Inc,
Westbrook, Maine) has been helpful in facilitating a rapid and accurate
diagnosis of CHF in cats presenting with respiratory distress and pleu-
ral effusion (PLEFF).6,7 However, noncardiac (NC) diseases, such as
severe respiratory or kidney disease, can increase NT-proBNP concen-
trations and increase the likelihood of false positive results.8 Point-of-
care lung ultrasound (LUS) and focused cardiac ultrasound (FCU) also
have shown promise in accelerating the emergency diagnosis of CHF
in cats.7,9–11 Lung ultrasound can suggest a diagnosis of cardiogenic
pulmonary edema by demonstrating the presence of ultrasonographic
artifacts called B-lines. These B-lines, also called “lung rockets,” are lin-
ear, hyperechoic, laser-like artifacts that extend from the pleural-
pulmonary interface to the far aspect of the ultrasound screen without
fading and that move synchronously with respiration.12–14 Many stud-
ies in humans12,15–17 and a few veterinary studies9,10,13,18,19 have
shown that the presence of numerous B-lines in patients presenting
with respiratory distress is suggestive of CHF. Conversely, the absence
of B-lines strongly refutes the diagnosis of CHF.11 However, although
B-lines are suggestive of CHF, these artifacts also can be present in
patients with other causes of fluid accumulation in the alveolar-
interstial lung spaces.12,15 The finding of LA enlargement on FCU per-
formed by trained clinicians improves the accuracy of CHF diagnosis
compared to physical examination alone in cats with respiratory dis-
tress.2,7 However, obtaining an optimal left atrium-to-aorta ratio
(LA : Ao) view can be difficult in animals experiencing respiratory dis-
tress, especially cats.
To our knowledge, no study has evaluated the relative diagnostic
utility of POC LUS, FCU, and NT-proBNP for diagnosis of CHF in a
cohort of cats with respiratory distress. Our primary goal was to com-
pare the diagnostic accuracy of each of these diagnostic tests in pre-
dicting a final diagnosis of CHF. Additionally, we sought to determine
if any combination of clinical variables or findings on these diagnostic
tests yielded optimal diagnostic accuracy. We hypothesized that POC
ultrasound findings (LUS and FCU) would have equal or higher diag-
nostic accuracy compared to POC NT-proBNP alone, and that a com-
bination of all diagnostic tests would offer superior diagnostic
accuracy compared with any single test.
2 | MATERIALS AND METHODS
Procedures were approved by the Institutional Animal Care and Use
Committee at both study sites (North Carolina State University and
Iowa State University). Informed owner consent was obtained for
each study participant.
Cats presented to the Small Animal Emergency and Critical Care
Services or Cardiology Services at each study site were prospectively
enrolled. Inclusion criteria were: (1) cats exhibiting increased respiratory
rate (>40 breaths per minute) and increased respiratory effort on physi-
cal examination; (2) a trained examiner was available to perform POC
ultrasound; and (3) blood was obtained for the POC NTproBNP test
within 2 hours of POC ultrasound (either before or after ultrasound).
Cats with PLEFF regardless of severity were included in our study. If
thoracocentesis was performed, the NT-proBNP test also was per-
formed on the pleural fluid. Exclusion criteria were: (1) the cat had a
respiratory disturbance suspected to be a pain response (ie, obvious
nonrespiratory and noncardiac cause of an abnormal breathing pat-
tern); or (2) the cat had a recent history of trauma. Empirical treatment
with furosemide before POC ultrasound was not an exclusion criterion.
Cats were stabilized with oxygen, sedation and other therapeutic
maneuvers at the discretion of the emergency or cardiology clinician.
Participating POC ultrasound examiners were cardiology and emer-
gency clinicians who had completed a 4-hours training session with an
experienced lung ultrasonographer and echocardiographer (T.C.
DeFrancesco and J.L. Ward). The trainee had to demonstrate profi-
ciency during 3–5 supervised examinations. All LUS examinations
were performed using compact portable ultrasound machines at each
center (ISU; CX50 CompactXtreme Ultrasound [model 101855], Phi-
lips Healthcare, Andover, Massachusetts; C8-5 Transducer (part #
FUS5124), Philips Healthcare, Andover, Massachusetts; NCSU;
Fukuda Denshi Ultrasound (model UF-760AG, Version 02), Tokyo,
Japan; Fukuda Denshi Transducer [model FUT-CA144-9P], Tokyo,
Japan) using a curvilinear probe with standardized settings (ultrasound
frequency, 5–8 MHz; depth, 4–6 cm).
The LUS examinations were performed on all cats using the previ-
ously described Vet BLUE protocol for LUS.9,12,13 Cats were scanned
in sternal recumbency. Starting on the right hemithorax, a 3-second
ultrasound cine loop was obtained at 4 acoustic windows on each side
of the patient's thorax at standardized locations, for a total of 8 sites
(see Figure 1). After the 4 right-sided views were obtained and before
scanning the left hemithorax, a single FCU cine loop was obtained and
recorded by the POC ultrasound examiner. This FCU view was a
2-dimensional short axis right parasternal view of the heart base opti-
mized for measurement of the LA : Ao ratio (see Figure 2). The opera-
tor recorded his or her real-time subjective assessment of LA size as
normal (LA : Ao of approximately 1 : 1) or enlarged (LA : Ao > 1.5) at
the time of the examination. Additionally, the 2-dimensional LA : Ao
ratio was measured at a later time by a board-certified cardiologist
(T.C. DeFrancesco and J.L. Ward) using standard methods, from the
first diastolic frame after aortic valve closure.20,21 Presence or
absence of pericardial effusion (PCEFF) also was noted from the
LA : Ao view and confirmed by later review by a board-certified cardi-
ologist (T.C. DeFrancesco and J.L. Ward).
For each Vet BLUE site, the examiner was asked to determine the
presence or absence of PLEFF, B-lines, and other sub-pleural abnor-
malities (Nodule [Nd], Shred [Sh], or Tissue [Ti] signs).14 A Nd sign was
defined as a small, well-marginated hypoechoic circular or ellipsoid
structure, with or without a hyperechoic distal border, and with or
without acoustic enhancement appearing as a B-line extending from
its distal border through the far field of the ultrasound screen.14,22–24
A Sh sign was an irregular discontinuity of the expected linear
pulmonary-pleural interface with hyperechoic foci within the consoli-
dation, representing lung consolidation with aeration analogous to a
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radiographic air bronchogram.14,22,23 A Ti sign appeared as linear to
triangular discontinuity or deviation from the expected pulmonary-
pleural interface, void of hyperechoic foci within the consolidation,
representing consolidation without aeration described as hepatization
of lung.14,22,23,25 Combinations of PLEFF, B-lines, and sub-pleural
abnormalities could be noted within a single Vet BLUE site (eg, a site
could contain both PLEFF and B-lines, or a combination of Sh sign and
B-lines).
In sites where B-lines were present, the maximum number of
B-lines within an intercostal space was recorded as 0, 1, 2, 3, >3 or infi-
nite.9 Infinite refers to the situation where B-lines are so numerous that
they are no longer discernable as individual B-lines (see Figure 1D). An
individual Vet BLUE site where either >3 or infinite B-lines were
recorded was scored as a “strong positive” site. A diagnosis of sus-
pected cardiogenic pulmonary edema on LUS was defined according to
the method established by a consensus panel for LUS in humans (the
so-called “Volpicelli method”)9,15 as a LUS examination that contained
at least 2 strong positive sites on each hemithorax. The total number of
B-lines in all 8 individual Vet BLUE sites then was summed to create a
“B-line score” for the overall LUS examination. For purposes of total B-
line score, >3 B-lines per ICS were counted as 4 B-lines for that site,
and infinite B-lines per ICS were counted as 10 B-lines for that site,
consistent with protocols used in humans.26 For example, a cat that
had 3 Vet BLUE sites each containing 2 B-lines, 3 Vet BLUE sites
FIGURE 1 Stylized photographic depiction of the VetBLUE technique for LUS (A) and representative LUS images (B-F). A, The ultrasound probe
is held horizontally at 4 sites on each hemithorax to record images. The LA : Ao focused cardiac ultrasound image is obtained from the right
hemithorax at approximately the Md site. Corresponding lung locations as viewed on a lateral thoracic radiograph are also shown. Cd,
caudodorsal; Cr, cranial; Md, middle; Ph, perihilar. B-F, Still B-mode image of LUS findings from cats, with rib shadows identified (*). B, LUS image
from a normal cat, showing presence of horizontal A-lines. C, LUS image from cat in respiratory distress, showing multiple B-lines. The B-lines are
visible as multiple linear hyperechoic artifacts extending from the pleural-pulmonary interface to the far edge of the screen. The cranial ICS con-
tains infinite B-lines (the artifacts coalesce and individual B-lines can no longer be discerned), while the caudal ICS contains >3 B-lines that can still
be recognized individually. D, LUS image with infinite B-lines at all ICSs. E, LUS image from a cat with large volume PLEFF; B-line artifacts are seen
within the PLEFF. F, LUS images from a cat with large volume PLEFF. ICS, intercostal space; LUS, lung ultrasound; PL, pleural effusion. Illustration
by Alice MacGregor Harvey, permission to print courtesy of North Carolina State University
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devoid of B-lines, and 2 Vet BLUE sites with infinite B-lines would have
a total B-line score of 2 + 2 + 2 + 0 + 0 + 0 + 10 + 10 = 26.
The POC NT-proBNP tests (SNAP Feline proBNP test, IDEXX
Laboratories, Inc, Westbrook, Maine) were performed according to
manufacturer's instructions using serum (and if available, PLEFF)
within 24 hours of venipuncture, by an individual blinded to final diag-
nosis. After a 10-minutes incubation time, the relative color density of
the sample (patient) spot was compared with the reference spot by
visual inspection. Results were recorded as either positive (abnormal)
when the color of the sample spot was equal to or darker than the ref-
erence spot or negative (normal) when the color of the sample spot
was lighter than the reference spot.
Final clinical diagnosis for cause of respiratory distress was deter-
mined by retrospective review of each patient's medical record by a
board-certified cardiologist (T.C. DeFrancesco and J.L. Ward) who was
blinded to the cat's NT-proBNP test results. The final diagnosis incor-
porated all other diagnostic test results, including thoracic radiographs
(TXR), echocardiography, airway sampling (tracheal wash or bronch-
oalveolar lavage), PLEFF cytology, and necropsy findings, as well as
response to treatment.
Statistical analyses were performed using commercial software
(MedCalc Version 17.6, MedCalc Software, Seoul, South Korea; NCSS
Version 10. NCSS LLC, Laysville, Utah). A prospective sample size cal-
culation extrapolated from the previous study of LUS in dogs and cats
with respiratory distress8 showed that 36 cats (18 with CHF, 18 with
NC disease) would be required to estimate diagnostic accuracy of LUS
within 10% with 95% confidence.8 Normality was assessed by the
Shapiro-Wilk test. Categorical data were summarized as frequencies
and proportions; quantitative data were summarized as mean +/–
standard deviation (SD) if normally distributed, and as median (range)
if non-normally distributed. Student's t-tests (continuous normally dis-
tributed data), Mann-Whitney log-rank tests (continuous non-
normally distributed data), or Fisher's exact or Chi-square analyses
(categorical data) were used to compare clinical data between cats
with a final diagnosis of CHF versus NC disease. Sensitivity and speci-
ficity were calculated for the association of LUS, FCU, and NT-
proBNP with final diagnosis of CHF. Univariate logistic regression
analysis was performed initially to assess continuous and categorical
variables for their utility in diagnosing CHF. Variables significant in the
univariate logistic regression analysis subsequently were entered into
a multivariate stepwise logistic regression analysis. Variables demon-
strating quasi-complete or complete separation in the univariate
logistic regression analysis were not entered into the multivariate
logistic regression analysis, but subsequently were evaluated by chi-
square analysis. Receiver operator curve analysis was performed on all
significant variables to identify diagnostic thresholds with optimal sen-
sitivity and specificity using the Youden index. Statistical significance
was set at P < .05 for all analyses.
3 | RESULTS
3.1 | Study population and clinical findings
Fifty-two cats initially met inclusion criteria for the study, but 1 cat
was not enrolled because it was too fractious to permit ultrasound
examination. The final study population of 51 cats comprised 35 cats
from North Carolina State University and 16 cats from Iowa State
University. Thirty-six cats were castrated males, whereas 15 were
spayed females. Domestic shorthair cats were most common
(n = 34). Other cat breeds represented included domestic longhair
cats (n = 8), Siamese (n = 3), Himalayan (n = 3), Maine Coon (n = 1),
Norwegian Forest Cat (n = 1), and Bengal (n = 1). Other clinical vari-
ables describing the study population are listed in Table 1. Point-of-
care ultrasound was performed by a board-certified cardiologist in
21 cases (41%), cardiology resident in 20 cases (39%), and emergency
clinician in 10 cases (20%). Study diagnostics (POC ultrasound and
NT-proBNP) were performed before any treatment in 40/51 (78%)
cats. Seven cats (14%) had furosemide administered before diagnostic
tests, whereas 4/51 (8%) cats had emergency thoracocentesis per-
formed before study diagnostic tests (all of which had residual PLEFF
identified on POC ultrasound). Subsequent diagnostic tests per-
formed to obtain a final diagnosis in study cats included TXR (47/51
cats, 92%), complete echocardiography (32/51 cats, 63%), and thora-
cocentesis with PLEFF analysis (23/51 cats, 45%). One cat each
underwent endotracheal wash, fine needle aspirate of a lung mass,
and necropsy.
Overall, 33 (65%) cats had a final diagnosis of CHF, whereas
18 (35%) were diagnosed with NC causes of respiratory distress.
Causes of CHF were hypertrophic cardiomyopathy (n = 23), hyperthy-
roid heart disease (n = 5), unclassified cardiomyopathy (n = 3), restric-
tive cardiomyopathy (n = 1), and unspecified cardiomyopathy
(n = 1).27 Five cats with CHF (5/33, 15%) had recently received IV
fluid treatment, and the etiology of CHF in these cases was suspected
to include a component of acute fluid overload. The most commonly
FIGURE 2 Still B-mode focused cardiac ultrasound short axis images of the base of the heart showing a normal left atrium (A), and a
subjectively enlarged left atrium (B,C). The normal ratio of the diameter of the LA to the diameter of the Ao should be 1 : 1. In addition to an
enlarged LA : Ao ratio, a scant amount of PCE is visualized in C
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diagnosed NC disease was neoplasia (9/18, 50%), including primary
lung tumor (n = 5) and metastatic neoplasia (n = 4). Other NC dis-
eases were idiopathic chylothorax (n = 4), feline asthma (n = 3), fungal
disease (n = 1, disseminated cryptococcosis), and suspected aerosol-
ized toxin exposure (n = 1).
No significant differences were detected between CHF and NC
groups in terms of age, sex, weight, rectal temperature, heart rate, or
presence of arrhythmia (see Table 1). Overall, 15/51 cats (29%) were
diagnosed with a heart murmur on auscultation, including 13/33 (39%)
cats diagnosed with CHF and 2/18 (11%) cats diagnosed with NC dis-
ease. The difference in murmur incidence between CHF and NC cats
was not statistically significant (P = .052). Thirteen cats (25%) had an S4
gallop noted on auscultation, all of which were diagnosed with CHF;
cats with CHF were more likely to have an S4 gallop than cats with NC
disease (P = .0017). The only other clinical finding that differed between
groups was respiratory rate, with NC cats having higher respiratory rates
on presentation compared to cats with CHF (78 +/– 30 breaths/minutes
versus 63 +/– 16 breaths/minutes, P = .024).
3.2 | Point-of-care thoracic imaging
Except for the single cat excluded from the study, performance of
LUS and FCU was technically feasible (all images obtained at all
described sites) in all cats. Lung ultrasound and FCU were completed
without difficulty in <5 minutes in 48/51 (94%) cats. In 3 cats, exam-
iners recorded that examination time was prolonged (5–10 minutes)
because of patient instability (n = 2) or behavioral noncompli-
ance (n = 1).
Overall, 44/51 (86%) of cats had at least 1 B-line identified on LUS,
including 32/33 (97%) cats with CHF and 12/18 (67%) cats with NC dis-
ease (see Table 2). Cats with CHF were more likely to have any B-lines
compared with cats with NC causes of respiratory distress (P = .0056)
TABLE 2 Thoracic ultrasound and POC cardiac biomarker testing in 51 cats with respiratory distress diagnosed with congestive heart failure or
NC disease
Parameter All cats CHF NC P-value
Number of cats 51 33 18 –
B-lines present, n (%) 44/51 (86.3) 32/33 (97.0) 12/18 (66.7) .0056*
Vet BLUE sites containing B-lines (#) 5 (0–8) 6 (0–8) 1 (0–8) .0026*
Strong positive Vet BLUE sites (#) 2 (0–8) 4 (0–8) 0.5 (0–7) <.001*
Volpicelli positive exam, n (%) 18/51 (35.3) 16/33 (48.5) 2/18 (11.1) .013*
Total B-line score (sum of 8 sites, #) 20 (0–74) 26 (0–74) 3.5 (0–34) <.001*
PLEFF present, n (%) 36/51 (70.6) 26/33 (78.8) 10/18 (55.6) .11
Vet BLUE sites containing PLEFF (#) 0 (0–8) 0 (0–8) 1.5 (0–8) .61
PCEFF present, n (%) 20/51 (39.2) 20/33 (60.6) 0/18 (0) <.001*
LA : Ao subjectively enlarged, n (%) 32/51 (62.7) 32/33 (97.0) 0/18 (0) <.001*
LA : Ao 1.8 +/– 0.6 2.1 +/– 0.5 1.2 +/– 0.2 <.001*
Blood NT-proBNP positive, n (%) 36/51 (70.6) 31/33 (93.9) 5/18 (27.8) <.001*
PLEFF NT-proBNP positive, n (%) 14/19 (73.7) 11/12 (91.7) 3/7 (42.9) .034*
Continuous data are presented as mean +/– SD if normally distributed, and as median (range) if non-normally distributed. Categorical data are pre-
sented as number and percent of cats with each finding. See text for definitions of strong positive vet BLUE sites and total B-line score.
Abbreviations: #, number; CHF, congestive heart failure; NC, noncardiac disease; LA : Ao, ratio of left atrial to aortic diameter; PLEFF, pleural
effusion; PCEFF, pericardial effusion; NT-proBNP, N-terminal pro-B-type natriuretic peptide; vet BLUE, veterinary bedside lung ultrasound
examination. Significant p-values (p < .05) are denoted with an asterisk (*).
TABLE 1 Clinical data for 51 cats in respiratory distress diagnosed with either congestive heart failure (CHF) or NC disease
Parameter All cats CHF NC P-value
Number of cats 51 33 18 –
Age (years) 10.3 +/– 3.7 10.5 +/– 3.6 10.0 +/– 4.1 .65
Male, n (%) 36/51 (70.6) 25/33 (75.8) 11/18 (61.1) .34
Body weight (kg) 5.3 +/– 1.5 5.0 +/– 1.1 5.8 +/– 1.9 .089
Body condition score 5.6 +/– 1.7 5.0 +/– 1.6 6.1 +/– 1.9 .17
Rectal temperature (F) 100.3 +/– 1.6 100.3 +/– 1.6 100.4 +/– 1.6 .82
Heart rate (per minute) 198.7 +/– 31.3 193.9 +/– 32.9 207 +/– 26.9 .14
Respiratory rate (per minute) 68 +/– 23 63 +/– 16 78 +/– 30 .024*
Murmur present, n (%) 15/51 (29.4) 13/33 (39.4) 2/18 (11.1) .052
Arrhythmia present, n (%) 6/51 (11.8) 5/33 (15.2) 1/18 (5.6) .41
S4 gallop present, n (%) 13/51 (25.5) 13/33 (39.4) 0/18 (0) .0017*
Continuous data are presented as mean +/– SD, whereas categorical data are presented as number and percentage of cats with each finding. Sig-
nificant P-values (P < .05) are denoted with an asterisk (*).
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and had a higher number of Vet BLUE sites containing any B-lines
(median, 6; range, 0–8) compared with NC cats (median, 1; range, 0–8;
P = .0026). Cats with CHF had a higher total B-line scores (median, 26;
range, 0–74) compared with NC cats (median, 3.5; range, 0–34;
P < .001) as well as a higher number of strong positive Vet BLUE sites
(sites with >3 or infinite B-lines) compared with NC cats (median, 4 versus
0.5; P < .001). Using previously established criterion9,15 that at least
2 strong positive sites on each hemithorax defines a positive LUS exami-
nation, Volpicelli positive examinations were more common in CHF cats
(16/33, 48.5%) compared with NC cats (2/18, 11.1%; P = .013).
Although CHF cats had more B-lines than NC cats by all mea-
sures, distribution of B-lines among individual Vet BLUE sites was rel-
atively uniform for both groups. For CHF cats, the Vet BLUE site
where B-lines were most commonly noted was the RPh site (81.8% of
CHF cats had B-line at this site), whereas the site least commonly con-
taining B-lines was the RCr site (B-lines present in 51.5% of CHF cats).
For NC cats, the Vet BLUE site where B-lines were most commonly
noted was the RCr site (55.6% of NC cats had B-lines at this site),
whereas the site least commonly containing B-lines was the RPh site
(B-lines present in 22.2% of NC cats). In both groups, occurrence of
B-lines among Vet BLUE sites was not statistically different from an
equal distribution (P = .896 for CHF, P = .617 for NC).
Subpleural LUS abnormalities (other than B-lines) were noted in
13 cats (25%). Seven cats had Sh, including 6 cats with CHF and 1 cat
with feline asthma. Four cats had Ti, including 2 cats with CHF, 1 cat
with feline asthma (and suspected mucus plugging of the airways), and
1 cat with pulmonary metastasis. Sh and Ti always occurred in con-
junction with B-lines at the same Vet BLUE site; presence of Sh was
associated with strong positive sites in 5/7 cats, and presence of Ti
was associated with strong positive sites in 3/4 cats. Three cats had
Nd, including 1 cat each diagnosed with disseminated fungal disease,
pulmonary metastasis, and primary lung tumor. Cats with NC disease
were more likely to have Nd compared to cats with CHF (P = .015).
A total of 36/51 (71%) cats had PLEFF identified on LUS, includ-
ing 26/33 (79%) cats with CHF and 10/18 (56%) cats with NC dis-
ease (see Table 2). Of 8 possible Vet BLUE sites, PLEFF was noted
in an average of 2.7 +/– 3.2 sites per cat. Incidence of PLEFF
(P = .11) and number of sites containing PLEFF (P = .48) did not
differ between cats with CHF and NC disease. Nineteen cats (37%)
had at least 1 site that contained both PLEFF and B-lines, with an
average of 1.0 +/– 1.5 such sites per cat. Coexistence of PLEFF and
B-lines was not more common in CHF cats compared with NC
cats (P = .37).
Pericardial effusion was noted on FCU in 20/51 cats (39%), all of
which were diagnosed with CHF (see Table 2). Cats with CHF were sig-
nificantly more likely to have PCEFF (20/33, 61%) compared with NC
cats (0/18, 0%; P < .0001). Volume of PCEFF was described as trace
(<3 mm) in 14 cats and mild (3–6 mm) in 6 cats. Subjective LA enlarge-
ment was noted in 32/51 (62.7%) cats, including 32/33 (97%) cats diag-
nosed with CHF and 0/18 (0%) cats diagnosed with NC disease
(P < .0001). Average quantitative LA : Ao was significantly higher in cats
with CHF (2.1 +/– 0.49) compared with NC cats (1.2 +/– 0.21;
P < .0001).
3.3 | Biomarker testing
Point-of-care NT-proBNP testing was performed on blood samples
from all cats. The SNAP test was visually positive in 36/51 (71%) cats,
including 31/33 (94%) cats diagnosed with CHF and 5/18 (28%) cats
diagnosed with NC disease. Point-of-care NT-proBNP testing also
was performed using samples of PLEFF in 19 cats. The SNAP test was
visually positive in 14/19 (74%) PLEFF samples, including 11/12
(92%) from CHF cats and 3/7 (43%) from cats with NC disease. Com-
pared to cats with NC disease, cats diagnosed with CHF were more
likely to have positive NT-proBNP tests performed on both blood
(P < .0001) and PLEFF (P = .034; Table 2).
3.4 | Diagnostic accuracy
Univariate logistical regression was performed to evaluate clinical,
LUS, FCU, and biomarker variables for association with a final diagno-
sis of CHF. Results for variables found to be significant in univariate
analysis are shown in Table 3. Two variables (subjective LA : Ao
enlargement and presence of PCEFF) showed quasi-complete separa-
tion on univariate regression, and Chi-square analyses were per-
formed to evaluate their association with CHF diagnosis and obtain
TABLE 3 Diagnostic accuracy of variables associated with final diagnosis of congestive heart failure (CHF) in univariate analysis
Parameter AUC
Optimal cutoff to
predict CHF Sensitivity (%) Specificity (%) P-Value
Respiratory rate 0.711 (0.567-0.830) <68 66.7 (48.2–82.0) 77.8 (52.4–93.6) .014
Vet BLUE sites containing B-lines 0.749 (0.608-0.860) >2 84.9 (68.1–94.9) 66.7 (41.0–86.7) .0016
Strong positive Vet BLUE sites 0.833 (0.703-0.923) >1 78.8 (61.1–91.0) 83.3 (58.6–96.4) <.001
Volpicelli positive exam 0.687 (0.542-0.809) – 48.5 (30.8–66.5) 88.9 (65.3–98.6) .0048
Total B-line score 0.822 (0.690-0.915) >4 87.9 (71.8–96.6) 66.7 (41.0–86.7) <.001
PCEFF present 0.803** (0.668-0.901) – 60.6 (42.1–77.1) 100 (81.5–100) <.001
LA : Ao subjectively enlarged 0.985** (0.903-1.00) – 97.0 (84.2–99.9) 100 (81.5–100) <.001
LA : Ao 0.981 (0.896-1.00) >1.5 93.9 (79.8–99.3) 94.4 (72.7–99.9) <.001
Blood NT-proBNP positive 0.831 (0.700-0.921) – 93.9 (79.8–99.3) 72.2 (46.5–90.3) <.001
Optimal cutoffs for prediction of CHF are listed for continuous variables; 95% confidence intervals for each result are listed in parentheses.
Abbreviations: AUC, area under the receiver operating characteristic curve; LA : Ao, ratio of left atrial to aortic diameter; PCEFF, pericardial
effusion; NT-proBNP, N-terminal pro-B-type natriuretic peptide; vet BLUE, veterinary bedside lung ultrasound examination.
**Indicates variables that displayed quasi-complete separation on univariate regression.
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ROC curves. The following variables were not significantly associated
with final diagnosis of CHF in univariate analysis (P > .05): age, sex,
body weight, body condition score, rectal temperature, heart rate,
presence of arrhythmia, presence of PLEFF, and number of sites posi-
tive for PLEFF. Although 2 variables (presence of heart murmur and
PLEFF NT-proBNP) were significant in a univariate analysis, the ROC
curves developed for these variables did not differ significantly from
the diagonal line (area under the curve [AUC] = 0.5).
Variables found to be significant in univariate analysis were
entered into a stepwise multivariate logistic regression model (respira-
tory rate, total B-line score, number of Vet BLUE sites containing B-
lines, number of strong positive Vet BLUE sites, Volpicelli exam posi-
tive, and blood NT-proBNP positive). Variables displaying quasi-
complete separation on univariate regression could not be entered
into the multivariate model. Additionally, LA : Ao was not included in
the model because its high discriminatory power in univariate analysis
nullified the significance of all other variables in multivariate analysis.
Two variables remained significant in the final multivariate regression:
number of strong positive Vet BLUE sites (P = .036) and blood NT-
proBNP (P = .001). Relative performance of this multivariate model
compared with univariate models for the quasi-separated and highly
discriminatory univariate variables in univariate analysis are shown in
Table 4.
3.5 | False positive and false negative results
Presence of B-lines on LUS incorrectly categorized some cats as hav-
ing CHF (false positives). Using the criterion of >1 strong positive Vet
BLUE site, LUS incorrectly classified 3 cats as having CHF, all of which
were diagnosed with neoplasia (primary pulmonary or metastatic).
False positives also occurred using the NT-proBNP SNAP test. Five
cats were incorrectly classified as having CHF based on a positive NT-
proBNP result, including 1 cat with feline asthma (LA : Ao 0.96) and
4 cats with neoplasia (LA : Ao 1.22, 1.30, 1.33, and 1.50). The FCU
variables of subjective LA : Ao enlargement and presence of PCEFF
were highly specific (100%) indicators of CHF, with no false positives
in our patient population.
All diagnostic tests failed to correctly identify at least 1 cat with
CHF (false negatives). Using the criterion of >1 strong positive site, LUS
missed the diagnosis of CHF in 7 cats. Of these cats, 6/7 had PLEFF,
5/7 had PCEFF, and 6/7 were positive on NT-proBNP SNAP test. The
NT-proBNP SNAP test missed the diagnosis of CHF in 2 cats. Both of
these cats had severe LA enlargement and PLEFF; 1 cat had PCEFF and
8 strong positive Vet BLUE sites, wheresa the other had a total B-line
score of 3 with no strong positive Vet BLUE sites. Subjective LA size
assessment produced only 1 false negative CHF diagnosis. This cat had
an LA : Ao of 1.30 on FCU, but a subsequent complete echocardiogram
identified hypertrophic cardiomyopathy with LA : Ao of 1.65, suggesting
that the FCU view underestimated true LA size in this cat.
4 | DISCUSSION
The POC diagnostic techniques (LUS, FCU, and NT-proBNP) used in
our study had good to excellent sensitivity and specificity for the diag-
nosis of CHF in cats with respiratory distress. Regarding LUS, the
presence of > 1 Vet BLUE site scoring “strongly positive” for B-lines
(>3 B-lines per site) was the criterion with the best diagnostic accu-
racy. This finding was 78.8% sensitive and 83.3% specific for a diagno-
sis of CHF. Accuracy of LUS in our study was lower than in a previous
study involving 24 cats, in which the Vet BLUE protocol was 87% sen-
sitive and 89% specific for a diagnosis of CHF.9 This difference likely
reflects differences in exclusion criteria between the 2 studies. In the
prior study, cats with moderate to severe PLEFF (fluid
accumulation > 1 cm) were deliberately excluded to avoid the possi-
bility that lung atelectasis secondary to effusion might have caused B-
lines independent of true pulmonary disease. In the our study, cats
were included regardless of the presence or volume of PLEFF. Cats
can manifest left-sided CHF in a variety of ways, including pulmonary
edema, PLEFF, PCEFF, or any combination thereof.4 Some cats with
CHF in our study had cavitary effusion (PLEFF or PCEFF or both)
without pulmonary edema, and without B-lines on LUS. Therefore, it
is logical that a B-line LUS criterion could have false negatives and
lower sensitivity for diagnosis of CHF in cats in which cardiogenic
fluid accumulation is primarily PLEFF. However, if lung atelectasis
does result in B-lines, PLEFF also could lead to false positive diagno-
ses of CHF on LUS; additional studies pre- and post-thoracocentesis
are needed to determine the effect of large-volume PLEFF on LUS
imaging.
Pleural effusion was quite common in our study regardless of
underlying diagnosis, occurring in 36/51 (70.6%) cats, including 26/33
(78.8%) CHF cats and 10/18 (55.6%) NC cats. Neither presence, vol-
ume, nor distribution of PLEFF was useful in discriminating between
CHF and NC disease. In a previous study, PLEFF was identified as a
manifestation of fluid accumulation in 51/100 (51%) cats with acute
CHF.4 The higher incidence of PLEFF in our study might reflect a bias
TABLE 4 Diagnostic accuracy for prediction of congestive heart failure (CHF) of the final multivariate regression model compared to highly
discriminatory individual parameters showing quasi-complete separation on univariate analysis
Parameter AUC Sensitivity (%) Specificity (%) P-value
Multivariate model: >1 Vet BLUE site strongly
positive for B-lines and blood NT-proBNP positive
0.895 (0.777-0.963) 75.8 (57.7–88.9) 88.9 (65.3–98.6) .0016
PCEFF present 0.803 (0.668-0.901) 60.6 (42.1–77.1) 100 (81.5–100) <.001
LA : Ao subjectively enlarged 0.985 (0.903-1.00) 97.0 (84.2–99.9) 100 (81.5–100) <.001
LA : Ao 0.981 (0.896-1.00 93.9 (79.8–99.3) 94.4 (72.7–99.9 <.001
Ninety-five percent confidence intervals for each result are reported in parentheses.
Abbreviations: AUC, area under the receiver operating characteristic curve; LA : Ao, ratio of left atrial to aortic diameter; PCEFF, pericardial
effusion; NT-proBNP, N-terminal pro-B-type natriuretic peptide; vet BLUE, veterinary bedside lung ultrasound examination.
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in the referred patient population (ie, primary care veterinarians might
elect to refer cats with known or suspected PLEFF to a tertiary care
center if they lack the equipment or expertise to perform thoraco-
centesis). The overall frequency of PLEFF in cats with respiratory dis-
tress in our study highlights the utility of POC ultrasound to identify
PLEFF and expedite therapeutic thoracocentesis.
Pulmonary neoplasia (primary pulmonary or metastatic) was the
most common NC cause of false positive LUS results in our study.
This finding differs from previous LUS studies in dogs, in which the
most common NC diseases associated with numerous B-lines were
acute respiratory distress syndrome, pulmonary thromboembolism,
and pneumonia.9,28 This difference likely reflects species differences
in the types of NC diseases causing respiratory distress. In the studies
of dogs, frequently diagnosed underlying diseases included pulmonary
thromboembolism, airway disease, and pneumonia. In our study of
cats, neoplasia was the most common NC disease, diagnosed in 9/18
(50%) cats. Because B-lines are caused by presence of alveolar or
interstitial infiltrates regardless of etiology, false positive results can
occur with any NC disease that causes significant alveolar or intersti-
tial pathology. Lung ultrasound findings therefore must be interpreted
in the context of relevant differential diagnoses for the patient
population.
The distribution of B-lines among Vet BLUE sites was relatively
uniform in cats with CHF in our study, and did not differ from that of
cats with NC disease. This observation is consistent with previous
studies of LUS in cats10,29 in which cats with CHF usually have B-lines
in all Vet BLUE sites (diffuse distribution). This finding is also consis-
tent with the typical radiographic appearance of pulmonary edema in
cats, often described as patchy, multifocal, or diffuse.5,29,30 Additional
subpleural LUS abnormalities other than B-lines (Sh, Ti, or Nd) were
seen in a minority of cats (25%). Shred most commonly were seen in
cats with CHF, usually associated with multiple Vet BLUE sites con-
taining infinite B-lines. This finding differs from a previous study of
LUS in coughing dogs28 in which Sh occurred most commonly in dogs
with bacterial pneumonia, and only were noted focally in a single,
gravity-dependent Vet BLUE site (Cr or Md). Similar to the study of
coughing dogs, however, all cats diagnosed with Nd in our study had
either fungal or neoplastic disease. Further research with larger sam-
ple sizes would be required to determine the diagnostic accuracy of
Nd or other subpleural abnormalities for the diagnosis of specific NC
diseases. Nonetheless, documentation of all LUS abnormalities at each
Vet BLUE site, in addition to B-lines, is recommended when perform-
ing POC LUS.14
Our study further supports the notion that LA enlargement identi-
fied on FCU strongly suggests CHF as the cause of respiratory distress
in cats. Subjective LA enlargement was noted in real-time by the
examiner in nearly all (32/33) cats diagnosed with CHF and in none of
the cats diagnosed with NC disease. Indeed, the criterion of subjective
LA enlargement (Yes or No) was 97.0% sensitive and 100% specific
for a diagnosis of CHF (AUC of 0.985). Quantitative LA enlargement
measured from FCU images also was highly diagnostic; a cutoff of
LA : Ao > 1.5 maximized accuracy (AUC 0.981) with a sensitivity
of 93.9% and specificity of 94.4% for detection of CHF. Because
these 2 indices (subjective and quantitative LA : Ao) both measure
the same variable (LA size), it is not surprising that both were highly
discriminatory for the diagnosis of CHF. We chose to measure both
indices in our study because we wanted to compare the performance
of subjective LA : Ao assessment as performed in “real-time” by the
POC ultrasound examiner to quantitative LA : Ao measurement of the
same image by a cardiologist. Interestingly, the subjective assessment
had slightly higher diagnostic accuracy than the objective measure-
ment in our study. However, these 2 variables showed significant
overlap in 95% confidence intervals for AUC, and thus this difference
could be because of chance (in fact, both indices had such high dis-
criminatory power that neither was entered into the multivariate anal-
ysis). Nonetheless, the LA is a complex 3-dimensional dynamic
chamber, whereas quantitative LA : Ao is a single 2-dimensional index
performed on a static image. It is possible that real-time LA assess-
ment truly does allow superior visualization of the entire LA and left
auricle throughout the cardiac cycle, allowing more accurate detection
of LA enlargement.
Previous clinical studies similarly have shown that increased LA
size in cats with respiratory signs strongly suggests CHF, especially in
cats with PLEFF.2,7 One study found that a maximal LA size of
>16.5 mm measured in B-mode from the right parasternal 4-chamber
long axis view had a sensitivity and specificity of 87% for a diagnosis
of CHF.2 In another study, the finding of an enlarged LA during an
emergency POC ultrasound increased the confidence and accuracy
for the diagnosis of CHF compared with physical examination alone.7
Our study and previous studies show that conversely, if LA size is nor-
mal, NC causes of respiratory distress are more likely.
Ours is the first study to demonstrate that the FCU finding of
even a trace amount of PCEFF in a cat with respiratory distress is
highly suggestive of CHF. Pericardial effusion was present in 20/33
(61%) cats with CHF in our study and in none of the cats (0/18, 0%)
with NC disease. A previous study of cats with acute CHF reported
that 23/100 (23%) cats had mild PCEFF on echocardiography.4 The
higher proportion of CHF cats with PCEFF in our study could be
explained by differences in ultrasound timing. In the prior study, echo-
cardiography was performed after 43% of cats had received diuretic
treatment,4 whereas only 14% of cats in our study received furose-
mide before POC ultrasound. Conversely, the largest retrospective
case series of cats with PCEFF reported that CHF was the most com-
monly diagnosed underlying cause of PCEFF, accounting for 113/146
(77%) cases; the remaining 23% of cats were diagnosed with NC dis-
eases including neoplasia or idiopathic PCEFF.31 In our study, no cat
with NC disease had PCEFF. This finding suggests that PCEFF is
highly specific for CHF in cats with respiratory distress, but the
absence of PCEFF does not rule out CHF. However, the amount of
PCEFF can be minimal, and PCEFF might be difficult to distinguish
from PLEFF, especially for a novice sonographer.
Point-of-care LUS and FCU had favorable diagnostic utility for
evaluating cats with respiratory distress in our study. The main advan-
tage of these POC thoracic ultrasound techniques is that they can be
performed quickly (while administering oxygen treatment, if needed)
with minimal additional distress to the cat and without the need for
clipping hair. For the majority of cats in our study (48/51), both US
examinations were completed in <5 minutes with no complications.
Three cats with extreme respiratory distress had more prolonged
(5–10 minutes) ultrasound examinations, with intermittent breaks to
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minimize stress. Another potential advantage is that these POC tech-
niques are cost efficient and can be performed by personnel with min-
imal training, thereby increasing the timeliness and accuracy of
diagnosis in these fragile patients. A study of veterinary interns and
(noncardiology) residents showed improved and acceptable diagnostic
accuracy for sonographic identification of atrial enlargement, PCEFF,
and PLEFF after 6 hours of training.32 In human medicine, the combi-
nation of FCU and LUS by emergency physicians has high and
improved diagnostic accuracy compared to conventional diagnostic
techniques.33,34 These POC ultrasound techniques, however, should
not replace more detailed evaluations with TXR or a comprehensive
echocardiogram by a cardiologist or other qualified specialist to con-
firm the initial POC assessment once the patient is more stable. How-
ever, POC imaging can allow a more accurate working diagnosis to
keep patients alive until more comprehensive testing can be per-
formed. One of the main drawbacks of POC ultrasound is that image
acquisition, more so than image interpretation, can be challenging in
certain cases, especially for a novice sonographer. Imaging difficulties
caused by inexperience or low-quality ultrasound equipment could
lead to misdiagnosis.
Our supports findings of previous studies regarding the useful-
ness of the biomarker NT-proBNP for the diagnosis of CHF in cats
presenting with respiratory distress. A positive POC NT-proBNP test
performed on a blood sample was 93.9% sensitive and 72.2% specific
for the diagnosis of CHF in our study. Previous studies have reported
high sensitivity (90%-93%) and specificity (80%-87%) of NT-pro-BNP
for diagnosis of CHF in cats with respiratory distress, depending on
what cut-off values and specific assays were used.35,36 However,
these initial studies employed a quantitative NT-proBNP assay, which
is available as a send-out test to commercial laboratories, hindering its
application in an emergency setting. A feline-specific POC NT-
proBNP ELISA assay (SNAP Feline proBNP test, IDEXX Laboratories,
Inc, Westbrook, Maine) has since been marketed and studied in both
symptomatic and asymptomatic cats. In a recent study of 33 cats with
respiratory distress, this POC NT-proBNP test demonstrated 100%
sensitivity and 86.7% specificity for the diagnosis of CHF.7 In cats
with PLEFF, the POC NT-proBNP test performed on plasma samples
also had good to excellent sensitivity (95.2%) and specificity (87.5%)
for differentiating CHF from NC causes of effusion. In comparison,
when using PLEFF (rather than plasma) as the test sample, the POC
test had excellent sensitivity (100%) but low specificity (64.7%).6 We
also evaluated the use of PLEFF samples for POC NT-proBNP testing
in 19 cats. The pleural fluid POC NT-proBNP results were positive in
11/12 (91.7%) cats with CHF and in 3/7 (42.9%) cats with NC causes
of PLEFF. The moderate to high rate of false positives in the pleural
fluid tests suggests that blood samples are preferred over pleural fluid
samples for POC NT-proBNP testing, and corroborates previous stud-
ies suggesting that the POC NT-proBNP test appears to be most help-
ful in ruling out (rather than ruling in) CHF in cats with respiratory
distress.6 However, diluting pleural fluid 1 : 1 with saline may increase
the specificity of POC NT-proBNP performed on PLEFF samples37
but this dilution technique was not used in our study. The advantage
of the POC NT-proBNP is its relatively low cost (as compared with an
ultrasound unit), as well as the speed and ease of performing the test
and interpreting results.
The only clinical variable that was independently associated with
a final diagnosis of CHF in our study was respiratory rate on presenta-
tion. Interestingly, cats with CHF had a lower average respiratory rate
than cats with NC disease (63 versus 78 breaths per minute). The
explanation for this finding is unclear. Cats with NC diseases (most
commonly neoplasia, idiopathic chylothorax, and feline asthma) may
have simply had more severe pulmonary or pleural space compromise
compared with cats with CHF. Alternatively, cats with CHF might
have displayed other nonrespiratory clinical signs (lethargy, inappe-
tence) that prompted owners to seek veterinary care at an earlier
stage of disease. Emergency treatment is unlikely to have played a
role, because respiratory rate was recorded on each cat's triage intake
form as part of an initial physical examination before any treatment.
Although the difference in respiratory rate between CHF and NC cats
was statistically significant, this finding is not likely to be clinically
important or useful in a triage setting. Degree of tachypnea should
not be used to stratify suspicion of CHF in cats. Indeed, respiratory
rate was not a significant variable in multivariate analysis and its addi-
tion did not improve diagnostic accuracy of the primary POC tests
(LUS, FCU, and NT-proBNP). No other clinical variables, including
heart rate, rectal temperature, and presence of a heart murmur, were
associated with a final diagnosis of CHF. These findings are somewhat
surprising. Given the pathophysiologic nature of heart disease, cats
with CHF might be expected to have higher heart rates, lower rectal
temperatures, and a higher incidence of heart murmurs compared
with cats with NC disease. These findings might be attributable to var-
iable presence of heart murmurs in cats with cardiomyopathy,3,38
spectrum of disease severity in cats with CHF (with only a subset hav-
ing evidence of low cardiac output), low statistical power or some
combination of these factors. Our results are similar to those of a pre-
vious study of LUS in 76 dogs and 24 cats, in which no clinical vari-
ables at presentation improved the diagnostic accuracy of LUS for
detection of CHF.9
With a variety of POC diagnostic modalities available, practi-
tioners naturally will seek the test (or combination of tests) that maxi-
mizes sensitivity and specificity for a diagnosis of CHF. The results of
our study suggest that the finding of subjective LA enlargement on
FCU by an experienced operator is the single best predictor of CHF in
a cat with respiratory distress. This finding is not surprising because
establishing the presence of clinically relevant structural heart disease
(as evidenced by LA enlargement) approximates the gold standard of
echocardiography in a triage setting. The finding of PCEFF, if present,
further confirms a diagnosis of CHF (100% specific in our study).
However, the 2 findings with the highest diagnostic utility
(LA enlargement and PCEFF) also are among most technically chal-
lenging for inexperienced ultrasonographers. Positioning and optimi-
zation of the LA : Ao view can be particularly problematic in a
compromised patient. Similarly, identification of trace to mild PCEFF
can be difficult, particularly in views also containing PLEFF or an
enlarged LA. In contrast, LUS is less technically demanding to perform,
and blood sampling for NT-proBNP requires no special expertise.
Therefore, when evaluating a cat for possible CHF, novice ultrasonog-
raphers may focus less on FCU findings, and instead rely more on the
presence of numerous B-lines on LUS combined with NT-proBNP
results. This approach is consistent with POC emergency management
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procedures in humans, where LUS and NT-proBNP are used together
to increase diagnostic accuracy with combined sensitivity and speci-
ficity approaching 100% in clinical trials.17,39 As with any diagnosis in
veterinary medicine, test results must be considered in the context of
the patient's signalment, history, and physical examination findings. In
patients in which clinical presentation is compatible with CHF, the
suite of POC diagnostic tests evaluated in our study can provide
useful information to increase or decrease the index of suspicion
for CHF.
Our study had several limitations. First, the number of study sub-
jects was limited (n = 51), and only 18 cats were diagnosed with NC
disease. This sample size naturally limits our statistical power, and
makes it particularly difficult to draw conclusions about patterns of
diagnostic findings in individual NC conditions. Second, patients were
enrolled as a convenience sample of cats presenting for respiratory
distress at referral teaching hospitals. Conducting our study at referral
institutions may have introduced bias in patient selection. Cats with
the most severe respiratory distress may have been underrepresented
(potentially being unstable or unsuitable for transport), and cats with
PLEFF may have been overrepresented (because of the previously dis-
cussed referral bias). Enrollment practices also may have led to exclu-
sion of some cats that presented after-hours when none of the
investigators was available to facilitate study enrollment. Third, the
majority of LUS and FCU examinations was performed by cardiolo-
gists or cardiology residents. Although our subjective impression was
that the required didactic training and supervised practice in LUS and
FCU increased proficiency of inexperienced examiners in performing
these techniques, the overall high level of operator experience may
have played a role in high diagnostic accuracy of LUS and FCU in our
study. Furthermore, ultrasound images were reviewed by only
1 blinded observer experienced in performing and interpreting POC
ultrasound. Previous work suggests that interobserver agreement in
LUS is high, even when comparing novice and experienced individ-
uals9 but interobserver agreement has not been assessed for FCU,
especially subjective assessment of LA size. Therefore, our results
may have been different with other operators or observers. Further
work is needed to determine intraobserver and interobserver observer
agreement of FCU and to evaluate the accuracy of POC imaging
modalities by less experienced ultrasonographers. Additionally, only
the LA : Ao view on FCU was used to evaluate presence of PCEFF in
our study. It is possible that the sensitivity of PCEFF for diagnosis of
CHF would have been higher had other views been obtained. A gen-
eral limitation to LUS and FCU is the requirement for a POC ultra-
sound machine. Disparities in ultrasound model, probes, and software
can lead to substantial differences in image quality. We intentionally
chose to use small, portable, moderately priced laptop ultrasound
units for our study to most closely approximate the equipment avail-
able in a primary care or emergency setting. In-house ultrasound units
are becoming more common in veterinary practices, and clinicians will
benefit from training and experience in POC techniques such as LUS
and FCU.
In our study, the POC diagnostic techniques of LUS, FCU, and
NT-proBNP were useful to diagnose CHF in a population of cats with
respiratory distress. The presence of subjective LA enlargement,
PCEFF, >1 site strongly positive for B-lines, and positive blood NT-
proBNP all were highly associated with a diagnosis of CHF. Point-of-
care ultrasound is a useful modality in the emergency setting and can
provide rapid triage information, particularly for cats in which respira-
tory distress limits other diagnostic evaluation.
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